These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 30797819)

  • 1. Serum promotes vasculogenic mimicry through the EphA2/VE-cadherin/AKT pathway in PC-3 human prostate cancer cells.
    Yeo C; Lee HJ; Lee EO
    Life Sci; 2019 Mar; 221():267-273. PubMed ID: 30797819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigallocatechin-3-Gallate Suppresses Vasculogenic Mimicry through Inhibiting the Twist/VE-Cadherin/AKT Pathway in Human Prostate Cancer PC-3 Cells.
    Yeo C; Han DS; Lee HJ; Lee EO
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31936664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sp1 Plays a Key Role in Vasculogenic Mimicry of Human Prostate Cancer Cells.
    Han DS; Lee EO
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resveratrol suppresses serum-induced vasculogenic mimicry through impairing the EphA2/twist-VE-cadherin/AKT pathway in human prostate cancer PC-3 cells.
    Han DS; Lee HJ; Lee EO
    Sci Rep; 2022 Nov; 12(1):20125. PubMed ID: 36418859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIF-1α induces VE-cadherin expression and modulates vasculogenic mimicry in esophageal carcinoma cells.
    Tang NN; Zhu H; Zhang HJ; Zhang WF; Jin HL; Wang L; Wang P; He GJ; Hao B; Shi RH
    World J Gastroenterol; 2014 Dec; 20(47):17894-904. PubMed ID: 25548487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leptin Promotes Vasculogenic Mimicry in Breast Cancer Cells by Regulating Aquaporin-1.
    Han DS; Lee EO
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ginsenoside Rg3 inhibition of vasculogenic mimicry in pancreatic cancer through downregulation of VE‑cadherin/EphA2/MMP9/MMP2 expression.
    Guo JQ; Zheng QH; Chen H; Chen L; Xu JB; Chen MY; Lu D; Wang ZH; Tong HF; Lin S
    Int J Oncol; 2014 Sep; 45(3):1065-72. PubMed ID: 24938458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIF-2α promotes the formation of vasculogenic mimicry in pancreatic cancer by regulating the binding of Twist1 to the VE-cadherin promoter.
    Yang J; Zhu DM; Zhou XG; Yin N; Zhang Y; Zhang ZX; Li DC; Zhou J
    Oncotarget; 2017 Jul; 8(29):47801-47815. PubMed ID: 28599281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VE-cadherin regulates EphA2 in aggressive melanoma cells through a novel signaling pathway: implications for vasculogenic mimicry.
    Hess AR; Seftor EA; Gruman LM; Kinch MS; Seftor RE; Hendrix MJ
    Cancer Biol Ther; 2006 Feb; 5(2):228-33. PubMed ID: 16481735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effects of compound DMBT on hypoxia-induced vasculogenic mimicry in human breast cancer.
    Li S; Zhang Q; Zhou L; Guan Y; Chen S; Zhang Y; Han X
    Biomed Pharmacother; 2017 Dec; 96():982-992. PubMed ID: 29208325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-expressed B7-H3 promotes vasculogenic mimicry formation rather than angiogenesis in non-small cell lung cancer.
    Fan X; Huang J; Hu B; Zhou J; Chen L
    J Cancer Res Clin Oncol; 2023 Sep; 149(11):8729-8741. PubMed ID: 37129607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-27a-3p suppresses tumor metastasis and VM by down-regulating VE-cadherin expression and inhibiting EMT: an essential role for Twist-1 in HCC.
    Zhao N; Sun H; Sun B; Zhu D; Zhao X; Wang Y; Gu Q; Dong X; Liu F; Zhang Y; Li X
    Sci Rep; 2016 Mar; 6():23091. PubMed ID: 26980408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of transgelin blocks interleukin-8 utilization and suppresses vasculogenic mimicry in breast cancer cells.
    Aikins AR; Kim M; Raymundo B; Kim CW
    Exp Biol Med (Maywood); 2017 Mar; 242(6):573-583. PubMed ID: 28058861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyphyllin I suppresses the formation of vasculogenic mimicry via Twist1/VE-cadherin pathway.
    Xiao T; Zhong W; Zhao J; Qian B; Liu H; Chen S; Qiao K; Lei Y; Zong S; Wang H; Liang Y; Zhang H; Meng J; Zhou H; Sun T; Liu Y; Yang C
    Cell Death Dis; 2018 Sep; 9(9):906. PubMed ID: 30185783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rictor regulates the vasculogenic mimicry of melanoma via the AKT-MMP-2/9 pathway.
    Liang X; Sun R; Zhao X; Zhang Y; Gu Q; Dong X; Zhang D; Sun J; Sun B
    J Cell Mol Med; 2017 Dec; 21(12):3579-3591. PubMed ID: 28699701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inhibitory effect of Qilan Capsules on the expressions of vasculogenic mimicry-related proteins in prostate cancer].
    Yu XJ; Li JJ; Yang F; Dong L; Wu TL; Chang DG
    Zhonghua Nan Ke Xue; 2018 Jun; 24(6):533-539. PubMed ID: 30173460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia promotes vasculogenic mimicry formation by inducing epithelial-mesenchymal transition in ovarian carcinoma.
    Du J; Sun B; Zhao X; Gu Q; Dong X; Mo J; Sun T; Wang J; Sun R; Liu Y
    Gynecol Oncol; 2014 Jun; 133(3):575-83. PubMed ID: 24589413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-angiogenic treatment promotes triple-negative breast cancer invasion via vasculogenic mimicry.
    Sun H; Zhang D; Yao Z; Lin X; Liu J; Gu Q; Dong X; Liu F; Wang Y; Yao N; Cheng S; Li L; Sun S
    Cancer Biol Ther; 2017 Apr; 18(4):205-213. PubMed ID: 28278077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ROCK is involved in vasculogenic mimicry formation in hepatocellular carcinoma cell line.
    Zhang JG; Li XY; Wang YZ; Zhang QD; Gu SY; Wu X; Zhu GH; Li Q; Liu GL
    PLoS One; 2014; 9(9):e107661. PubMed ID: 25238232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ZEB2 promotes vasculogenic mimicry by TGF-β1 induced epithelial-to-mesenchymal transition in hepatocellular carcinoma.
    Yang Z; Sun B; Li Y; Zhao X; Zhao X; Gu Q; An J; Dong X; Liu F; Wang Y
    Exp Mol Pathol; 2015 Jun; 98(3):352-9. PubMed ID: 25818166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.